JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 50 filers reported holding JANUX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,632,973 | -15.1% | 360,414 | 0.0% | 1.11% | +48.1% |
| Q2 2023 | $4,278,114 | -1.9% | 360,414 | 0.0% | 0.75% | -16.6% |
| Q1 2023 | $4,361,009 | -8.1% | 360,414 | 0.0% | 0.90% | -11.8% |
| Q4 2022 | $4,746,652 | -2.7% | 360,414 | 0.0% | 1.02% | -10.2% |
| Q3 2022 | $4,880,000 | +10.9% | 360,414 | 0.0% | 1.14% | -3.0% |
| Q2 2022 | $4,401,000 | -25.5% | 360,414 | -12.5% | 1.17% | -21.1% |
| Q1 2022 | $5,906,000 | -27.3% | 411,871 | 0.0% | 1.49% | -5.6% |
| Q4 2021 | $8,126,000 | -8.8% | 411,871 | 0.0% | 1.58% | +12.7% |
| Q3 2021 | $8,909,000 | -41.3% | 411,871 | -32.3% | 1.40% | -25.3% |
| Q2 2021 | $15,168,000 | – | 607,949 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |